Increased susceptibility of mice to Salmonella infection following in vivo treatment with the substance P antagonist, spantide II.

Kincy-Cain, T; Bost, K L

Kincy-Cain, T; Bost, K L.

Affiliation

Kincy-Cain T; Department of Microbiology and Immunology, Tulane University Medical Center, New Orleans, LA 70112, USA.

J Immunol ; 157(1): 255-64, 1996 Jul 01.

Article in En | MEDLINE | ID: mdl-8683123

Subject(s)

Salmonella Infections, Animal/etiology; Salmonella Infections, Animal/immunology; Substance P/analogs & derivatives; Substance P/antagonists & inhibitors; Administration, Oral; Amino Acid Sequence; Animals; Base Sequence; Cells, Cultured; Disease Susceptibility; Female; Interferon-gamma/biosynthesis; Interleukin-12/biosynthesis; Leukocytes, Mononuclear/drug effects; Leukocytes, Mononuclear/immunology; Lymphocyte Activation/drug effects; Macrophage Activation/drug effects; Mice; Mice, Inbred BALB C; Molecular Sequence Data; RNA, Messenger/biosynthesis; Receptors, Neurokinin-1/biosynthesis; Receptors, Neurokinin-1/genetics; Salmonella Infections, Animal/mortality; Substance P/administration & dosage; Substance P/biosynthesis; Substance P/genetics; Substance P/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Salmonella Infections, Animal / Substance P Limits: Animals Language: En Journal: J Immunol Year: 1996 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links